行情

NSPR

NSPR

INSPIREMD
AMEX

实时行情|Nasdaq Last Sale

1.050
-0.280
-21.05%
已收盘, 17:56 11/12 EST
开盘
1.290
昨收
1.330
最高
1.290
最低
1.010
成交量
47.40万
成交额
--
52周最高
11.99
52周最低
1.010
市值
203.52万
市盈率(TTM)
-0.0994
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

NSPR 新闻

  • 沪指低开震荡 纳指再创新高、期金连跌四日
  • 新浪财经.2小时前
  • 美国最大牛奶公司Dean Foods申请破产保护
  • 澎湃新闻.3小时前
  • 多数分析师仍预期日央行继续宽松 但相反看法者大增
  • 新浪财经综合.3小时前
  • OPEC已陷入恶性循环?减产变相提升美页岩油市场份额
  • 汇通网.3小时前

更多

所属板块

医疗设备、用品及经销
+0.68%
医疗设备和用品
+0.81%

热门股票

名称
价格
涨跌幅

NSPR 简况

InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.
展开

Webull提供InspireMD Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。